Eledon Pharmaceuticals, Inc. (ELDN)
2.30
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
2.30
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Market Cap : 186.05M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 186.05M |
| October 22, 2026 | 186.05M |
| October 21, 2026 | 182.81M |
| October 20, 2026 | 182.41M |
| October 19, 2026 | 174.73M |
| October 16, 2026 | 172.30M |
| October 15, 2026 | 183.62M |
| October 14, 2026 | 182.01M |
| October 13, 2026 | 189.29M |
| October 12, 2026 | 197.38M |
| October 09, 2026 | 200.61M |
| October 08, 2026 | 195.76M |
| October 07, 2026 | 195.76M |
| October 06, 2026 | 198.18M |
| October 05, 2026 | 202.23M |
| October 02, 2026 | 201.42M |
| October 01, 2026 | 196.97M |
| September 30, 2026 | 204.66M |
| September 29, 2026 | 202.23M |
| September 28, 2026 | 213.55M |
| September 25, 2026 | 214.36M |
| September 24, 2026 | 216.79M |
| September 23, 2026 | 220.02M |
| September 22, 2026 | 233.78M |
| September 21, 2026 | 217.60M |
| Date | Value |
|---|---|
| September 18, 2026 | 211.94M |
| September 17, 2026 | 214.36M |
| September 16, 2026 | 215.98M |
| September 15, 2026 | 219.22M |
| September 14, 2026 | 224.07M |
| September 11, 2026 | 224.88M |
| September 10, 2026 | 224.88M |
| September 09, 2026 | 228.11M |
| September 08, 2026 | 237.01M |
| September 04, 2026 | 244.29M |
| September 03, 2026 | 237.01M |
| September 02, 2026 | 241.87M |
| September 01, 2026 | 243.48M |
| August 31, 2026 | 241.06M |
| August 28, 2026 | 258.85M |
| August 27, 2026 | 268.56M |
| August 26, 2026 | 270.99M |
| August 25, 2026 | 280.69M |
| August 24, 2026 | 275.84M |
| August 21, 2026 | 279.08M |
| August 20, 2026 | 284.74M |
| August 19, 2026 | 287.16M |
| August 18, 2026 | 292.83M |
| August 17, 2026 | 289.59M |
| August 14, 2026 | 286.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 5.636 |
| Price | 2.30 |
| Earnings Yield | -43.06% |